Astrazeneca (AZN) Return on Invested Capital (2009 - 2026)

Astrazeneca's Return on Invested Capital history runs 18 years deep, the most recent figure standing at 0.01% for Q2 2026.

• In Q2 2026, Return on Invested Capital changed 0.0% year-over-year to 0.01%; the TTM figure through Jun 2026 stood at 0.01% (changed 0.0% YoY), while the FY2025 annual figure was 0.0%, changed 0.0% from the prior year.
• Return on Invested Capital for Q2 2026 stood at 0.01%, down from 0.01% in the prior quarter.
• The five-year high for Return on Invested Capital was 0.02% in Q3 2024, with the low at 0.0% in Q2 2022.
• The 5-year median for Return on Invested Capital is 0.01% (2025), against an average of 0.01%.
• The sharpest annual moves came in 2022 and 2025: Return on Invested Capital rose 1 bps in 2022, then decreased 1 bps in 2025.
• Astrazeneca's Return on Invested Capital stood at 0.0% in 2022, then soared by 291 bps to 0.02% in 2023, then rose by 3 bps to 0.02% in 2024, then retreated by 26 bps to 0.01% in 2025, then slipped by 6 bps to 0.01% in 2026.
• Business Quant data shows AZN's Return on Invested Capital at 0.01% in Q2 2026, 0.01% in Q1 2026, and 0.01% in Q4 2025.